IPO registrations (S-1, F-1) · Registrants
Better Therapeutics, Inc.
- SEC CIK
- 1832415 · filings on EDGAR ↗
- Former names
- Mountain Crest Acquisition Corp II (2020–2021)
- Registration
- Form S-1, first filed 2020-12-21, last 2024-02-06; 4 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2021-01-11; declared effective 2021-01-07; withdrawal requested 2024-03-01
- Industry (SIC)
- Services-Health Services 8000
- Incorporated in
- DE
- Business address
- 548 MARKET ST. #49404, San Francisco, CA 94101
- EDGAR entity type
- operating
- Insiders and CEO pay
- Better Therapeutics, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2021-01-11, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $50,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MCAD
- Lead underwriters
- J.P. Morgan
- Syndicate
- Chardan
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Better Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: Better Therapeutics, Inc. EXACT (CIK (EXACT))
Filings 26
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-12-21 | S-1 | S-1 (registration) | Mountain Crest Acquisition Corp II | 0001213900-20-043878 ↗ |
| 2021-01-04 | S-1/A | S-1/A (amendment) | Mountain Crest Acquisition Corp II | 0001213900-21-000170 ↗ |
| 2021-01-07 | EFFECT | EFFECT (declared effective) | Mountain Crest Acquisition Corp II | 9999999995-21-000078 ↗ |
| 2021-01-11 | 424B4 | 424B4 (final prospectus) | Mountain Crest Acquisition Corp II | 0001213900-21-001442 ↗ |
| 2021-10-12 | EFFECT | EFFECT (declared effective) | Mountain Crest Acquisition Corp II | 9999999995-21-003845 ↗ |
| 2021-11-29 | S-1 | S-1 (registration) | Better Therapeutics, Inc. | 0001193125-21-341358 ↗ |
| 2021-12-08 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-21-004614 ↗ |
| 2022-04-06 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-22-000839 ↗ |
| 2022-12-07 | S-1 | S-1 (registration) | Better Therapeutics, Inc. | 0001193125-22-300232 ↗ |
| 2023-04-06 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-23-000842 ↗ |
| 2023-04-25 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-23-001045 ↗ |
| 2023-04-25 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-23-001046 ↗ |
| 2023-10-16 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-23-002987 ↗ |
| 2023-10-27 | S-1/A | S-1/A (amendment) | Better Therapeutics, Inc. | 0001193125-23-265163 ↗ |
| 2023-12-13 | S-1 | S-1 (registration) | Better Therapeutics, Inc. | 0001193125-23-294469 ↗ |
| 2023-12-18 | S-1/A | S-1/A (amendment) | Better Therapeutics, Inc. | 0001193125-23-296879 ↗ |
| 2023-12-21 | S-1/A | S-1/A (amendment) | Better Therapeutics, Inc. | 0001193125-23-301323 ↗ |
| 2023-12-27 | S-1/A | S-1/A (amendment) | Better Therapeutics, Inc. | 0001193125-23-303257 ↗ |
| 2023-12-27 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-23-003760 ↗ |
| 2024-02-06 | S-1/A | S-1/A (amendment) | Better Therapeutics, Inc. | 0001193125-24-024856 ↗ |
| 2024-03-01 | RW | RW (withdrawal request) | Better Therapeutics, Inc. | 0001193125-24-054323 ↗ |
| 2024-05-28 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-24-001652 ↗ |
| 2024-05-28 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-24-001653 ↗ |
| 2024-05-28 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-24-001654 ↗ |
| 2024-05-28 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-24-001655 ↗ |
| 2024-05-28 | EFFECT | EFFECT (declared effective) | Better Therapeutics, Inc. | 9999999995-24-001656 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-01-04 | S-1/A | registration statement | $10.00 | - | - | 0 | primary document; price sentence | document ↗ | ||
| 2021-01-11 | 424B4 | final prospectus | $10.00 | 5,000,000 | $50,000,000 | Nasdaq MCAD | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Haight Nelson | Director | 1 | 2021 | ||
| Liu Dong | Director,Officer,TenPercentOwner | Chief Financial Officer | 4 | 2021 | |
| Liu Suying | Director; Director,Officer,TenPercentOwner | Chief Executive Officer | 6 | 2021–2022 | |
| Milbourn Todd T. | Director | 1 | 2021 | ||
| Mountain Crest Capital LLC | TenPercentOwner | 4 | 2021 | ||
| Zhang Wenhua | Director | 1 | 2021 | ||
| Appelbaum Kevin J | Director,Officer,TenPercentOwner | Chief Executive Officer | 6 | 2021–2022 | |
| Armanino Andrew J. | Director | 11 | 2021–2023 | ||
| Berman Mark A. | Officer | Chief Medical Officer | 5 | 2021–2023 | |
| Carmona Richard H | Director | 5 | 2021–2023 | ||
| David P. Perry 2015 Trust | TenPercentOwner | 5 | 2021–2024 | ||
| Heinen Mark | Officer | Chief Financial Officer; See Remarks | 9 | 2021–2023 | |
| Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | TenPercentOwner | 6 | 2021–2022 | ||
| LAVIZZO-MOUREY RISA J | Director | 6 | 2021–2023 | ||
| Parker Geoffrey M. | Director | 10 | 2021–2023 | ||
| PERRY DAVID P | Director,Officer,TenPercentOwner | Executive Chairman; See Remarks | 10 | 2021–2024 | |
| Wynholds Kristin | Officer | Chief Product Officer | 5 | 2021–2023 | |
| Zamirowski Justin | Officer | Chief Commercial Officer | 4 | 2021–2022 | |
| Granger Elder | Director | 8 | 2021–2023 | ||
| KARBE FRANK | Director,Officer | Chief Executive Officer; See Remarks | 6 | 2022–2023 | |
| Georgianna Maule-Ffinch 2015 Trust | TenPercentOwner | 1 | 2023 | ||
| Miller Leslie A. | Officer | Principal Accounting Officer | 2 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-01-23 | Better Therapeutics, Inc. | Biotechnology | $250,000 | $250,000 | 1 | 1 |
| 2023-08-11 | Better Therapeutics, Inc. | Biotechnology | $2,114,998 | $2,114,998 | 10 | 1 |
| 2023-04-21 | Better Therapeutics, Inc. | Biotechnology | $6,500,001 | $6,500,001 | 9 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Better Therapeutics, Inc. | CA | Form D private offerings | CIK (EXACT) |
| Patent assignee | BETTER THERAPEUTICS, INC. | CA | Patents (USPTO) | name and state |
| SEC filer | Better Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Better Therapeutics, Inc. | CA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Health Services, CA first:
- PARALLAX HEALTH SCIENCES, INC. CA
- Healthcare of Today, Inc CA
- Omada Health, Inc. CA
- DIAMOND HITTS PRODUCTION INC CA
- LifeStance Health Group, Inc. AZ
- ACCELERA INNOVATIONS, INC. CO
- InnovAge Holding Corp. CO
- Everside Health Group, Inc. CO
- BIRNER DENTAL MANAGEMENT SERVICES INC CO
- GeneDx Holdings Corp. CT
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Services-Health Services · Health